Impact of hepatitis B core antibody (anti HBc) seropositivity on interferon/iribavirin treatment response in patients with chronic hepatitis C
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.108, sa.2, ss.65-69, 2007 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 108 Sayı: 2
- Basım Tarihi: 2007
- Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.65-69
- Anahtar Kelimeler: hepatitis B, antibody, antiHBc-seropositivity, interferon, ribavirin, chronic hepatitis C
- Dokuz Eylül Üniversitesi Adresli: Hayır
Özet
AntiHBc seropositivity among patients with chronic HCV infection is not a rare entity (57.14 %). We observed that antiHBc antibody seropositivity does not have a significant impact on treatment responses to interferon/ribavirin therapy in patients for chronic HCV infection in contrast to some reports in the literature.